Aegis Medicines Pvt Ltd - Company Profile

It is a pharma private limited company based in Pune, Maharashtra, India, established in 1993.
1993 Pune, Maharashtra, India Under Liquidation
Last Updated:
Access Report
About Aegis Medicines Pvt Ltd

Aegis Medicines Pvt Ltd, a under liquidation private limited company, was established on 23 July 1993 in Pune, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U99999PN1993PTC073083. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹6.24 Cr.

It upholds a compliant status. Its leadership includes Girish Siriram Juneja (Irp/Rp/Liquidator), Mukesh Khathuria (Irp/Rp/Liquidator), Ayub Gaffar Syed (Director). Past directors included Raziuddin Bashiruddin Shaikh. It holds ₹55.24 Cr open charges and ₹55.24 Cr settled loans. Its latest AGM occurred on 16 August 2022, with the balance sheet filed on 31 March 2022. It is based at A-502 Kumar Gulmohar Cts No. 1436 Survey No. 70A/1/2/2B Wanowrie Pune 4110, 40., Pune, Maharashtra, 411040.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U99999PN1993PTC073083

  • Registration Number

    073083

  • Incorporation Date

    23 July 1993

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹6.24 Cr

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Under Liquidation

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 6.24 Cr
  • Company Age 32 Year, 7 Months
  • Last Filing with ROC 31 Mar 2022
  • Open Charges ₹ 55.24 Cr
  • Satisfied Charges ₹ 55.24 Cr
  • Revenue Growth **** -100.00%
  • Profit Growth **** -518.47%
  • Ebitda **** -19242.22%
  • Net Worth -705.54%
  • Total Assets -11.02%
Company report

Aegis Medicines Pvt Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aegis Medicines Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aegis Medicines Pvt Ltd?
Current Directors
Name Designation Appointment Date Status
Girish Siriram Juneja Irp/Rp/Liquidator 06 Apr 2023 Current
Mukesh Khathuria Irp/Rp/Liquidator 18 Sep 2024 Current
Ayub Gaffar Syed Director 23 Jul 1993 Current
Ayesha Ayub Syed Director 23 Jul 1993 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Jun 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aegis Medicines.

Aegis Medicines Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 518.47% decrease in profit. The company's net worth observed a substantial decline by a decrease of 705.54%.

Aegis Medicines revenue growth over time
Aegis Medicines profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -100.00%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -11.02%
*******
*******
*******
*******
Profit or Loss
*******
 -518.47%
*******
*******
*******
*******
Net Worth
*******
 -705.54%
*******
*******
*******
*******
EBITDA
*******
 -19242.22%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aegis Medicines?

In 2022, Aegis Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹552,400,000.00

Satisfied Charges

₹552,400,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 55.24 Cr
Latest Charge Details
Date Lender Amount Status
29 Jan 2013 State Bank Of India ₹32.02 Cr Satisfied
31 Dec 2009 State Bank Of India ₹23.22 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Aegis Medicines?

Unlock and access historical data on people associated with Aegis Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aegis Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aegis Medicines's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aegis Medicines
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 29 Jan 2013 via Charge ID 10406822 with State Bank Of India was fully satisfied on 05 Apr 2025. was completed.

  • Charges

    The activity A charge registered on 31 Dec 2009 via Charge ID 10199259 with State Bank Of India was fully satisfied on 05 Apr 2025. was completed.

  • Director Appointment

    Mukesh Khathuria was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 18 Sep 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.

  • Director Appointment

    The activity Girish Siriram Juneja was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 06 Apr 2023 & has been associated with this company since 2 years 11 months . was completed.

  • Annual General Meeting

    Progress on Aegis Medicines Pvt Ltd last Annual general meeting of members was held on 16 Aug 2022 as per latest MCA records. was documented.

  • Balance Sheet

    Aegis Medicines Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Pune. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aegis Medicines Pvt Ltd?

The CIN of Aegis Medicines Pvt Ltd is U99999PN1993PTC073083.

Where is Aegis Medicines Pvt Ltd headquartered?

Aegis Medicines Pvt Ltd is headquartered at A-502 Kumar Gulmohar Cts No. 1436 Survey No. 70A/1/2/2B Wanowrie Pune 4110, 40., Pune, Maharashtra, 411040.

When was Aegis Medicines Pvt Ltd incorporated?

Aegis Medicines Pvt Ltd was incorporated on 23 July 1993.

Who are the current directors of Aegis Medicines Pvt Ltd?

The current directors of Aegis Medicines Pvt Ltd are

What is the primary industry of Aegis Medicines Pvt Ltd?

The primary industry of Aegis Medicines Pvt Ltd is Manufacturing.

Is Aegis Medicines Pvt Ltd a listed company?

Aegis Medicines Pvt Ltd is unlisted.

What is the capital structure of Aegis Medicines Pvt Ltd?

The authorized capital of Aegis Medicines Pvt Ltd is ₹10.00 Cr, and the paid-up capital is ₹6.24 Cr.

What is the compliance status of Aegis Medicines Pvt Ltd?

The compliance status of Aegis Medicines Pvt Ltd is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available